Contact
Assistant
In response to new business models, accelerated timelines, and unforeseen market dynamics, healthcare companies are seeking to innovate rapidly and effectively to meet new challenges. A key criterion for success is the adoption of cutting-edge tools that derisk and accelerate the drug development process. Investment in these tools pays dividends across a company's pipeline.
Principal Investigators Christina Chase , Anette Hosoi
Join industry leaders at our highly anticipated MIT Houston conference, Future-Proofing Your Operations, and gain the insights needed to navigate the dramatic changes driven by global economic forces, emerging technologies, and evolving government policies. This event will explore the transformative power of artificial intelligence (AI), essential workforce development strategies, groundbreaking advancements in manufacturing, shifting international trade patterns, and the impact of recent U.S. legislation on industrial policy.